Skip to main content

Select Drug Profiles

Perspectives
Corporate Culture of Health: Elusive and Expensive
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization
Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH
Stakeholder Perspective
Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
Atheer A. Kaddis, PharmD
Read More
Original Research, Pulmonary
Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan
Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD
Stakeholder Perspective
Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence
F. Randy Vogenberg, PhD, FASHP
Read More
In the Literature, Oncology
Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes
Read More
FDA Approvals, In the News
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Read More
FDA Approvals, In the News
Mixed Findings in Annual Cancer Statistics Report
Read More
FDA Approvals, In the News
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
Perspectives
Paying Tribute to Geno J. Merli, MD, MACP
David B. Nash, MD, MBA
Read More
FDA Approvals, In the News
Recap of FDA Drug Approvals in 2019
Read More
Original Research
Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias-Rodriguez, MD; Kamala Nola, PharmD, MS
Read More
Page 41 of 244
Results 401 - 410 of 2438